5am Ventures
SEC-registered investment adviser.
- Website
- HTTP://WWW.5AMVENTURES.COM
- HQ
- CA
5AM Ventures is an investment firm focused on funding and building next-generation life sciences companies.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Series A, Series B, Growth |
| Sectors | Biotech, Life sciences and research tools | Not enough dated deals | Biotech, Healthtech, Medical devices, Life sciences and research tools |
| Regions | Not stated | Not enough dated deals | CA, MA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2003 | 3 | Biotech, Life sciences and research tools, Healthtech |
| 2004 | 2 | Biotech, Healthtech, Life sciences and research tools |
| 2005 | 4 | Biotech, Healthtech, Life sciences and research tools |
| 2006 | 4 | Biotech, Healthtech, Life sciences and research tools |
| 2007 | 4 | Biotech, Healthtech |
| 2008 | 9 | Biotech, Healthtech, Medical devices |
| 2009 | 10 | Biotech, Healthtech, Life sciences and research tools |
| 2010 | 9 | Healthtech, Biotech, Medical devices |
| 2011 | 4 | Biotech, Healthtech, Manufacturing |
| 2012 | 12 | Biotech, Healthtech, Life sciences and research tools |
| 2013 | 7 | Biotech, Healthtech, Medical devices |
| 2014 | 8 | Biotech, Healthtech, Life sciences and research tools |
| 2015 | 11 | Biotech, Healthtech, Medical devices |
| 2016 | 11 | Biotech, Healthtech, Medical devices |
| 2017 | 8 | Biotech, Healthtech, Medical devices |
| 2018 | 20 | Biotech, Healthtech, Medical devices |
| 2019 | 10 | Biotech, Healthtech, Medical devices |
| 2020 | 5 | Biotech, Life sciences and research tools, Medical devices |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2010 | 0 | 0 | 1 | 3 | 4 |
| 2011 | 0 | 0 | 2 | 2 | 0 |
| 2012 | 0 | 0 | 1 | 1 | 5 |
| 2013 | 0 | 0 | 5 | 0 | 1 |
| 2014 | 0 | 0 | 3 | 3 | 1 |
| 2015 | 0 | 1 | 3 | 3 | 1 |
| 2016 | 0 | 0 | 5 | 5 | 1 |
| 2017 | 0 | 1 | 0 | 4 | 2 |
| 2018 | 0 | 1 | 9 | 6 | 4 |
| 2019 | 0 | 0 | 2 | 3 | 5 |
| 2020 | 0 | 0 | 2 | 3 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| 5AM Ventures VII, L.P. | approx. 2021 | $450M (Form D) | Follow-ons only |
03 · People across funds
- Andrew Schwab, Managing Member of the General Partner of the Issuer
5AM Ventures VII, L.P. (Named on Form D)
- Kush Parmar, Managing Member of the General Partner of the Issuer
5AM Ventures VII, L.P. (Named on Form D)
- Andy J. Schwab, Managing Partner
On the team page, not linked to a fund
- Aniqa Tasnim, PhD, Senior Associate
On the team page, not linked to a fund
- Anna Yaeger, Chief Investment Officer and Partner
On the team page, not linked to a fund
- Arthur Tzianabos, PhD, Venture Partner
On the team page, not linked to a fund
- Brian Daniels, MD, Venture Partner
On the team page, not linked to a fund
- Deborah Palestrant, PhD, Partner, Executive Chair, 4:59 Initiative
On the team page, not linked to a fund
- Elliott Levy, MD, Venture Partner
On the team page, not linked to a fund
- John D. Diekman, PhD, FOUNDING PARTNER
On the team page, not linked to a fund
- John Kelly, Partner, Chief Financial Officer & Chief Operating Officer
On the team page, not linked to a fund
- Joshua Grass, Venture Partner
On the team page, not linked to a fund
- Katie Bodner Spielberg, PhD, Principal
On the team page, not linked to a fund
- Kush M Parmar, MD, PhD, Managing Partner
On the team page, not linked to a fund
- Lidia Liu, Senior Research Analyst
On the team page, not linked to a fund
- Mason Freeman, MD, Venture Partner
On the team page, not linked to a fund
- Max Farina, MD, Principal
On the team page, not linked to a fund
- Michael Calore, Partner, Head of Investor Relations
On the team page, not linked to a fund
- Scott M. Rocklage, PhD, FOUNDING PARTNER
On the team page, not linked to a fund
- Steve Hitchcock, PhD, Venture Partner
On the team page, not linked to a fund
- Travis Fleming, PhD, Analyst
On the team page, not linked to a fund
- Wen Jiang, Research Analyst
On the team page, not linked to a fund
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026